TODD LASCO to Adjuvants, Immunologic
This is a "connection" page, showing publications TODD LASCO has written about Adjuvants, Immunologic.
Connection Strength
0.031
-
Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen. Vaccine. 2010 Jan 22; 28(4):1084-93.
Score: 0.018
-
NIH pre-clinical screening program: overview and current status. Tuberculosis (Edinb). 2005 Jan-Mar; 85(1-2):25-8.
Score: 0.013